Equitable Holdings’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Sell
31,823
-1,160
-4% -$54.1K 0.01% 830
2025
Q4
$1.6M Buy
32,983
+818
+3% +$40.5K 0.01% 717
2025
Q3
$1.52M Buy
32,165
+8,222
+34% +$397K 0.01% 707
2025
Q2
$1.16M Buy
23,943
+4,848
+25% +$248K 0.01% 758
2025
Q1
$1.06M Buy
19,095
+3,244
+20% +$176K 0.01% 694
2024
Q4
$764K Buy
15,851
+2,247
+17% +$114K 0.01% 750
2024
Q3
$784K Buy
13,604
+2,225
+20% +$120K 0.01% 745
2024
Q2
$552K Buy
11,379
+3,249
+40% +$157K 0.01% 802
2024
Q1
$395K Buy
8,130
+922
+13% +$45K ﹤0.01% 886
2023
Q4
$358K Buy
7,208
+1,297
+22% +$63.4K ﹤0.01% 879
2023
Q3
$317K Buy
5,911
+1,969
+50% +$105K ﹤0.01% 854
2023
Q2
$212K Buy
+3,942
New +$212K ﹤0.01% 967

Other funds holding SNY

Equitable Holdings's SNY Position: Q1 2026 in Review

Equitable Holdings reduced its Sanofi (SNY) stake by 3.5% in Q1 2026, selling an estimated $54.1K and leaving 31,823 shares worth $1.54M. The position accounts for 0.01% of the portfolio, ranked #830.

Equitable Holdings first reported a position in SNY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.6M in Q4 2025. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Equitable Holdings held 31,823 shares of Sanofi worth $1.54M as of Q1 2026.
  • Equitable Holdings sold 1,160 Sanofi shares in Q1 2026, an estimated $54.1K.
  • Sanofi made up 0.01% of Equitable Holdings's portfolio in Q1 2026, its #830 holding.
  • Equitable Holdings first reported a position in Sanofi in Q2 2023 and has held it in 12 quarters since.
  • Equitable Holdings's Sanofi position peaked at $1.6M in Q4 2025.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.